BACKGROUND:
METHODS:
In this randomised controlled trial, we recruited newly
diagnosed HIV-infected women, who were 32 or less weeks pregnant, from 89
antenatal care clinics in Kinshasa, Democratic Republic of Congo, and randomly
assigned (1:1) them to either the intervention group or the control group using
computer-based randomisation with varying block sizes of four, six, and eight.
The intervention group received compensation on the condition that they
attended scheduled clinic visits and accepted offered PMTCT services (US$5,
plus US$1 increment at every subsequent visit), whereas the control group
received usual care. Outcomes assessed included retention in care at 6 weeks'
post partum and uptake of PMTCT services, measured by attendance of all
scheduled clinic visits and acceptance of proposed services up to 6 weeks' post
partum. Analyses were by intention to treat. This trial is registered with
ClinicalTrials.org, number NCT01838005.
FINDINGS:
INTERPRETATION:
Purchase full article at: http://goo.gl/v1xZ3I
By: Yotebieng M1, Thirumurthy H2, Moracco KE3, Kawende B4, Chalachala JL4, Wenzi LK4, Ravelomanana NL5, Edmonds A5, Thompson D5, Okitolonda EW4,Behets F6.
- 1The Ohio State University, College of Public Health, Division of Epidemiology, Columbus, OH, USA; The University of North Carolina at Chapel Hill, Department of Epidemiology, Chapel Hill, NC, USA. Electronic address: yotebieng.2@osu.edu.
- 2The University of North Carolina at Chapel Hill, Department of Health Policy and Management, Chapel Hill, NC, USA.
- 3The University of North Carolina at Chapel Hill, Department of Health Behavior, Chapel Hill, NC, USA.
- 4The University of Kinshasa, School of Public Health, Kinshasa, Democratic Republic of Congo.
- 5The University of North Carolina at Chapel Hill, Department of Epidemiology, Chapel Hill, NC, USA.
- 6The University of North Carolina at Chapel Hill, Department of Epidemiology, Chapel Hill, NC, USA; The University of North Carolina at Chapel Hill, Department of Social Medicine, Chapel Hill, NC, USA.
- Lancet HIV. 2016 Feb;3(2):e85-93. doi: 10.1016/S2352-3018(15)00247-7.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment